Index of reports
> Cases with Myalgia (26)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Femara (Letrozole) where reactions include myalgia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Femara side effects in female
Reported by a physician from Japan on 2012-08-14
Patient: female, weighing 47.0 kg (103.4 pounds)
Reactions: Jaundice, Abdominal Pain, Visual Acuity Reduced, Tricuspid Valve Incompetence, Pyrexia, Erythema, Myalgia, Malaise, Neck Pain, C-Reactive Protein Increased, Oedema, Endocarditis, Urinary Retention, Tenderness, Cardiothoracic Ratio Increased, Musculoskeletal Pain, Streptococcal Infection, Endophthalmitis, Mitral Valve Incompetence, Swelling, Dysuria, Sepsis, Vision Blurred, Immune System Disorder, Blood Pressure Fluctuation, Blood Pressure Decreased, Inflammation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zometa
Dosage: 4 mg per administration, unk
End date: 2011-10-01
Femara
Dosage: 2.5 mg, qd
Administration route: Oral
Indication: Breast Cancer Metastatic
Femara
Dosage: 2.5 mg, daily
Administration route: Oral
Start date: 2011-12-29
Other drugs received by patient: Herceptin; Anastrozole
Possible Femara side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-30
Patient: female
Reactions: Back Pain, Pain, Aggression, Myalgia, Thinking Abnormal, Arthralgia, Mental Disorder, Musculoskeletal Stiffness, Gait Disturbance, Anuria
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Femara
Dosage: 2.5 mg, daily
Administration route: Oral
Indication: Breast Cancer
Letrozole
Dosage: 2.5 mg, unk
Indication: Breast Cancer
Possible Femara side effects in 57 year old female
Reported by a physician from Germany on 2012-07-19
Patient: 57 year old female, weighing 52.0 kg (114.4 pounds)
Reactions: Myelofibrosis, Bone Pain, Pancytopenia, Pyrexia, Paraesthesia, Myalgia, Meningeal Disorder, DRY Mouth, Colitis, Splenomegaly
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zometa
Dosage: 4 mg, every 4 week
Indication: Metastases To Bone
Start date: 2009-10-01
End date: 2011-12-01
Femara
Dosage: 1 df, unk
Indication: Breast Cancer
Start date: 2009-10-01
End date: 2011-12-01
Possible Femara side effects in female
Reported by a pharmacist from France on 2012-03-15
Patient: female
Reactions: Myalgia, Tendon Pain, Arthralgia, Diarrhoea, Palpitations, Gait Disturbance, Headache, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Femara
Dosage: 1 df daily
Administration route: Oral
Indication: Breast Cancer
Start date: 2011-12-30
End date: 2012-01-04
Zolpidem
Dosage: 1 df, daily
Administration route: Oral
Start date: 2012-01-08
Other drugs received by patient: Vitamin B-12; Acetaminophen; Ferrous Fumarate; Glucophage; Pravastatin; Atacand; Levothyroxine Sodium
Possible Femara side effects in female
Reported by a consumer/non-health professional from Iceland on 2012-03-14
Patient: female
Reactions: Myalgia, Arthralgia, Insomnia, Hyperhidrosis, Muscle Tightness
Drug(s) suspected as cause:
Femara
Possible Femara side effects in female
Reported by a pharmacist from France on 2012-03-02
Patient: female
Reactions: Myalgia, Tendon Pain, Palpitations, Arthralgia, Diarrhoea, Headache, Gait Disturbance, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Femara
Dosage: 1 df daily
Administration route: Oral
Indication: Breast Cancer
Start date: 2011-12-30
End date: 2012-01-04
Zolpidem
Dosage: 1 df, daily
Administration route: Oral
Start date: 2012-01-08
Other drugs received by patient: Pravastatin; Ferrous Fumarate; Vitamin B-12; Levothyroxine Sodium; Glucophage; Atacand; Acetaminophen
Possible Femara side effects in 57 year old female
Reported by a consumer/non-health professional from Germany on 2012-03-02
Patient: 57 year old female
Reactions: Bone Pain, Urticaria, Extrasystoles, Arrhythmia, Myalgia, Hot Flush, Fatigue, Arthralgia, Joint Swelling, Dizziness
Drug(s) suspected as cause:
Femara
Possible Femara side effects in female
Reported by a physician from Belgium on 2012-02-28
Patient: female
Reactions: Myalgia, Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased
Drug(s) suspected as cause:
Femara
Dosage: 2.5 mg, daily
Indication: Breast Cancer
Start date: 2011-08-01
Herceptin
Dosage: 120 mg, qw
Indication: Breast Cancer
Tasigna
Dosage: 300 mg, daily
Indication: Chronic Myeloid Leukaemia
Start date: 2011-02-01
Other drugs received by patient: Pantoprazole; Elthyrone; Metamizole Sodium Monohydrate; Spiriva; Lexotan; Loramet; Escitalopram Oxalate; Duragesic-100; Perdolan; Ramipril; Duragesic-100
Possible Femara side effects in female
Reported by a pharmacist from France on 2012-02-16
Patient: female
Reactions: Myalgia, Tendon Pain, Arthralgia, Diarrhoea, Palpitations, Gait Disturbance, Headache, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Femara
Dosage: 1 df daily
Administration route: Oral
Indication: Breast Cancer
Start date: 2011-12-30
End date: 2012-01-04
Zolpidem
Dosage: 1 df, daily
Administration route: Oral
End date: 2012-01-08
Other drugs received by patient: Pravastatin; Vitamin B-12; Ferrous Fumarate; Glucophage; Acetaminophen; Levothyroxine Sodium; Atacand
Possible Femara side effects in female
Reported by a physician from Germany on 2012-01-23
Patient: female, weighing 80.0 kg (176.0 pounds)
Reactions: Asthma, Goitre, Bronchial Obstruction, Vaginal Haemorrhage, Upper Respiratory Tract Infection, Oesophagitis, Vulvovaginal Dryness, Raynaud's Phenomenon, Nail Psoriasis, Dislocation of Vertebra, Epistaxis, Phlebitis, Hiatus Hernia, Drug Intolerance, General Physical Health Deterioration, Lung Hyperinflation, Psoriatic Arthropathy, Osteoporosis, Muscle Tightness, Laryngitis, Myalgia, Fatigue, Transient Ischaemic Attack, Gastrooesophageal Reflux Disease, Sinusitis, Calcium Deficiency, Psoriasis, Arrhythmia, Mental Impairment, Arthralgia, Alopecia, Sexual Dysfunction, Bronchitis, Obstructive Airways Disorder, Spinal Osteoarthritis, Feeling Abnormal, Arthritis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Femara
Dosage: 2.5 mg, unk
Administration route: Oral
Indication: Breast Cancer
Start date: 2006-01-01
Femara
Dosage: 2.5 mg, unk
Administration route: Oral
Start date: 2007-01-01
Other drugs received by patient: Vitamin D; Ibuprofen; Rheuma Valverde; Diltiazem HCL; Adriamycin + Cyclophosphamide; Boniva; Jodthyrox; Boniva; Dekristol; Canephron; Bisphosphonates; Micardis; Symbicort Metered; Pravastatin
Possible Femara side effects in 60 year old female
Reported by a physician from United States on 2012-01-18
Patient: 60 year old female, weighing 60.0 kg (132.0 pounds)
Reactions: Femur Fracture, Tooth Extraction, Hand Fracture, Post Procedural Haematoma, Fracture Nonunion, Fall, Osteoporosis Postmenopausal, Poor Quality Sleep, Foot Fracture, Myalgia, Postoperative Wound Infection, Arthropathy, Haematocrit Decreased, Drug Administration Error, Bone Density Decreased, Bone Disorder, LOW Turnover Osteopathy, Migraine, Intervertebral Disc Protrusion, Lumbar Radiculopathy, Skin Disorder, Appendix Disorder, Osteoarthritis, Haemoglobin Decreased, Rhinitis Allergic, Staphylococcal Infection, Salmonellosis, Tooth Disorder, Metastases To Bone
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Fosamax
Administration route: Oral
Start date: 2004-03-24
End date: 2008-01-01
Alendronate Sodium
Administration route: Oral
Indication: Osteoporosis Prophylaxis
Start date: 2008-03-17
End date: 2009-05-01
Fosamax
Administration route: Oral
Start date: 2004-03-24
End date: 2008-01-01
Fosamax
Administration route: Oral
Indication: Osteoporosis
Start date: 2003-10-01
End date: 2009-08-01
Femara
Indication: Breast Cancer
Start date: 2006-10-01
End date: 2007-05-01
Fosamax
Administration route: Oral
Indication: Osteoporosis Prophylaxis
Start date: 2003-10-01
End date: 2009-08-01
Alendronate Sodium
Administration route: Oral
Indication: Osteoporosis
Start date: 2008-03-17
End date: 2009-05-01
Other drugs received by patient: Effexor; Tamoxifen Citrate
Possible Femara side effects in female
Reported by a physician from Belgium on 2012-01-18
Patient: female
Reactions: Myalgia, Blood Lactate Dehydrogenase Increased, Blood Creatinine Increased
Drug(s) suspected as cause:
Herceptin
Dosage: 120 mg, qw
Indication: Breast Cancer
Tasigna
Dosage: 300 mg, daily
Indication: Chronic Myeloid Leukaemia
Start date: 2011-02-01
Femara
Dosage: 2.5 mg, daily
Indication: Breast Cancer
Start date: 2011-08-01
Other drugs received by patient: Ramipril; Duragesic-100; Lexotan; Elthyrone; Escitalopram Oxalate; Spiriva; Metamizole Sodium Monohydrate; Pantoprazole; Loramet; Perdolan; Duragesic-100
Possible Femara side effects in female
Reported by a consumer/non-health professional from Iceland on 2012-01-11
Patient: female
Reactions: Myalgia, Arthralgia, Insomnia, Muscle Tightness, Hyperhidrosis
Drug(s) suspected as cause:
Femara
Possible Femara side effects in female
Reported by a physician from Belgium on 2012-01-09
Patient: female
Reactions: Myalgia, Blood Lactate Dehydrogenase Increased, Blood Creatinine Increased
Drug(s) suspected as cause:
Femara
Dosage: 2.5 mg, daily
Indication: Breast Cancer
Start date: 2011-08-01
Tasigna
Dosage: 300 mg, daily
Indication: Chronic Myeloid Leukaemia
Start date: 2011-02-01
Herceptin
Dosage: 120 mg, qw
Indication: Breast Cancer
Other drugs received by patient: Perdolan; Ramipril; Sipralexa; Metamizole Sodium Monohydrate; Pantoprazole; Spiriva; Elthyrone; Loramet; Lexotan; Duragesic-100
Possible Femara side effects in 47 year old female
Reported by a consumer/non-health professional from United States on 2011-12-27
Patient: 47 year old female, weighing 69.8 kg (153.6 pounds)
Reactions: Myalgia, Arthralgia, Pain in Extremity, Hepatotoxicity, Headache
Drug(s) suspected as cause:
Femara
Possible Femara side effects in female
Reported by a physician from United States on 2011-12-27
Patient: female
Reactions: Night Sweats, Myalgia, Hot Flush, Arthralgia, Bone Pain, Arthritis
Drug(s) suspected as cause:
Herceptin
Femara
Dosage: 2.5 mg, qd, oral
Administration route: Oral
Indication: Inflammatory Carcinoma of THE Breast
Start date: 2010-09-03
End date: 2010-12-01
Other drugs received by patient: Probiotics (NO Ingredients / Substances); Atenolol; Calcium Carbonate; Zoloft; Coenzyme Q10; Magnesium (Magnesium); Zantac; Maxzide; Vitamin D; Zocor; Aspirin; Centrum Silver (Ascorbic Acid, Calcium, Minerals Nos, Retinol, Tocophe; Folic Acid
Possible Femara side effects in female
Reported by a consumer/non-health professional from United States on 2011-12-27
Patient: female
Reactions: Myalgia, Arthralgia, Memory Impairment, Arthritis
Drug(s) suspected as cause:
Femara
Possible Femara side effects in female
Reported by a consumer/non-health professional from United States on 2011-12-27
Patient: female
Reactions: Myalgia, Back Pain, General Physical Condition Abnormal, Arthralgia, Osteoporosis, Dizziness, Bone Density Decreased
Drug(s) suspected as cause:
Femara
Other drugs received by patient: Antihypertensive Drugs (NO Ingredients / Substances)
Possible Femara side effects in 80 year old female
Reported by a physician from United States on 2011-12-23
Patient: 80 year old female
Reactions: Myalgia, Arthralgia, Arthritis
Drug(s) suspected as cause:
Femara
Possible Femara side effects in 60 year old female
Reported by a physician from United States on 2011-12-09
Patient: 60 year old female, weighing 60.0 kg (132.0 pounds)
Reactions: Femur Fracture, Tooth Extraction, Hand Fracture, Post Procedural Haematoma, Fracture Nonunion, Fall, Osteoporosis Postmenopausal, Foot Fracture, Poor Quality Sleep, Myalgia, Postoperative Wound Infection, Haematocrit Decreased, Drug Administration Error, Bone Disorder, Bone Density Decreased, LOW Turnover Osteopathy, Migraine, Skin Disorder, Lumbar Radiculopathy, Appendix Disorder, Osteoarthritis, Haemoglobin Decreased, Rhinitis Allergic, Staphylococcal Infection, Salmonellosis, Tooth Disorder
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Fosamax
Administration route: Oral
Indication: Osteoporosis
Start date: 2003-10-01
End date: 2009-08-01
Fosamax
Administration route: Oral
Start date: 2004-03-24
End date: 2008-01-01
Alendronate Sodium
Administration route: Oral
Indication: Osteoporosis
Start date: 2008-03-17
End date: 2009-05-01
Fosamax
Administration route: Oral
Indication: Osteoporosis Prophylaxis
Start date: 2003-10-01
End date: 2009-08-01
Fosamax
Administration route: Oral
Start date: 2004-03-24
End date: 2008-01-01
Femara
Indication: Breast Cancer
End date: 2007-05-01
Alendronate Sodium
Administration route: Oral
Indication: Osteoporosis Prophylaxis
Start date: 2008-03-17
End date: 2009-05-01
Other drugs received by patient: Effexor; Tamoxifen Citrate
Possible Femara side effects in 61 year old female
Reported by a health professional (non-physician/pharmacist) from Germany on 2011-12-01
Patient: 61 year old female
Reactions: Myelofibrosis, Relapsing Fever, Bone Pain, Pancytopenia, Paraesthesia, Myalgia, Meningeal Disorder, DRY Mouth, Splenomegaly
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zometa
Indication: Metastases To Bone
Femara
Indication: Breast Cancer
Possible Femara side effects in female
Reported by a physician from Belgium on 2011-11-22
Patient: female
Reactions: Myalgia, Blood Lactate Dehydrogenase Increased, Blood Creatinine Increased
Drug(s) suspected as cause:
Femara
Dosage: 2.5 mg, daily
Indication: Breast Cancer
Start date: 2011-08-01
Tasigna
Dosage: 300 mg, daily
Indication: Chronic Myeloid Leukaemia
Start date: 2011-02-01
Other drugs received by patient: Perdolan; Ramipril; Elthyrone; Herceptin; Loramet; Metamizole Sodium Monohydrate; Lexotan; Spiriva; Duragesic-100; Pantoprazole; Sipralexa
Possible Femara side effects in 60 year old female
Reported by a physician from United States on 2011-11-18
Patient: 60 year old female, weighing 60.0 kg (132.0 pounds)
Reactions: Femur Fracture, Hand Fracture, Post Procedural Haematoma, Fall, Fracture Nonunion, Osteoporosis Postmenopausal, Foot Fracture, Poor Quality Sleep, Myalgia, Haematocrit Decreased, Postoperative Wound Infection, Drug Administration Error, Bone Disorder, Bone Density Decreased, LOW Turnover Osteopathy, Migraine, Lumbar Radiculopathy, Skin Disorder, Appendix Disorder, Osteoarthritis, Haemoglobin Decreased, Rhinitis Allergic, Staphylococcal Infection, Salmonellosis, Tooth Disorder
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Fosamax
Administration route: Oral
Indication: Osteoporosis Prophylaxis
Start date: 2003-10-01
End date: 2009-08-01
Fosamax
Administration route: Oral
Indication: Osteoporosis
Start date: 2003-10-01
End date: 2009-08-01
Femara
Indication: Breast Cancer
End date: 2007-05-01
Other drugs received by patient: Effexor; Tamoxifen Citrate
Possible Femara side effects in female
Reported by a physician from Belgium on 2011-11-17
Patient: female
Reactions: Myalgia, Blood Lactate Dehydrogenase Increased, Blood Creatinine Increased
Drug(s) suspected as cause:
Femara
Indication: Breast Cancer
Start date: 2011-08-01
Tasigna
Indication: Chronic Myeloid Leukaemia
Start date: 2011-02-01
Other drugs received by patient: Herceptin
Possible Femara side effects in 57 year old female
Reported by a consumer/non-health professional from Germany on 2011-11-17
Patient: 57 year old female
Reactions: Urticaria, Extrasystoles, Bone Pain, Arrhythmia, Myalgia, Hot Flush, Fatigue, Joint Swelling, Arthralgia, Dizziness
Drug(s) suspected as cause:
Femara
Possible Femara side effects in 60 year old female
Reported by a physician from United States on 2011-10-25
Patient: 60 year old female, weighing 60.0 kg (132.0 pounds)
Reactions: Femur Fracture, Hand Fracture, Post Procedural Haematoma, Fracture Nonunion, Fall, Osteoporosis Postmenopausal, Poor Quality Sleep, Foot Fracture, Myalgia, Haematocrit Decreased, Postoperative Wound Infection, Drug Administration Error, Bone Disorder, Bone Density Decreased, LOW Turnover Osteopathy, Migraine, Skin Disorder, Lumbar Radiculopathy, Appendix Disorder, Osteoarthritis, Haemoglobin Decreased, Rhinitis Allergic, Staphylococcal Infection, Salmonellosis
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Femara
Indication: Breast Cancer
End date: 2007-05-01
Fosamax
Administration route: Oral
Indication: Osteoporosis
Start date: 2003-10-01
End date: 2009-08-01
Fosamax
Administration route: Oral
Indication: Osteoporosis Prophylaxis
Start date: 2003-10-01
End date: 2009-08-01
Other drugs received by patient: Effexor; Tamoxifen Citrate
|